Entropy Technologies LP Makes New $248,000 Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Entropy Technologies LP acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 2,700 shares of the medical device company’s stock, valued at approximately $248,000.

Other large investors have also added to or reduced their stakes in the company. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares during the period. International Assets Investment Management LLC purchased a new position in Cooper Companies during the third quarter valued at approximately $46,727,000. Swedbank AB lifted its holdings in Cooper Companies by 14.0% in the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after acquiring an additional 200,000 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after purchasing an additional 194,118 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of several recent analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Wells Fargo & Company increased their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Price Performance

COO stock opened at $93.68 on Friday. The stock has a market cap of $18.70 billion, a price-to-earnings ratio of 48.04, a price-to-earnings-growth ratio of 2.41 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The business has a fifty day moving average of $94.15 and a two-hundred day moving average of $99.76.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the previous year, the company earned $0.87 earnings per share. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.